We have recently demonstrated that AICAR was an efficient inhibitor of retinoblastoma cell proliferation in vitro through S-phase arrest, decrease of cyclins A and E, and partial inhibition of the mTOR pathway [28]. Here, CCNA2 is linked to retinoblastoma.